Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 47 of 1934 for:    Sexually Transmitted Diseases | NIH

Developing a Dyadic Intervention for Sexually Transmitted Infection (STI)/HIV Prevention in Youth

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03275168
Recruitment Status : Recruiting
First Posted : September 7, 2017
Last Update Posted : February 5, 2019
Sponsor:
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
Johns Hopkins University

Brief Summary:
This pilot project will evaluate the feasibility, acceptability, and preliminary effectiveness of a couples-based behavioral intervention [COUPLES] that augments individual evidence-based interventions with joint health education counseling for STI-affected AYA dyads within a primary care setting.

Condition or disease Intervention/treatment Phase
Exposure to Sexually Transmissible Disorder (Event) Behavioral: Intervention Behavioral: Individual evidence-based STI/HIV prevention intervention Not Applicable

Detailed Description:
While public health programs have demonstrated modest success in reducing the adolescent and young adult (AYA) risk for STI/HIV, significant health disparities remain. The risk of STI/HIV is not uniform among AYA. AYA residing in segregated urban communities with high STI prevalence and complicated sexual networks face even greater risk for disease and associated complications. Additional supports designed to increase engagement in care and reduce STI acquisition and transmissions are urgently needed to meet the sexual health and reproductive health goals for the nation. Overwhelmingly, AYA STI prevention interventions have targeted individuals and individual-level factors. While effective, these interventions do not adequately address other important influences affecting AYA risk for STI/HIV, such as partner or relationship influences on sexual decision-making and behavior. Partner notification and treatment is a key strategy for disease control and has previously been tested among adults for STI/HIV prevention work but has yet to be evaluated for AYA. Our prior research demonstrates that AYAs with complicated STIs are likely to notify their partners to seek treatment (88-92%); however, AYAs receiving brief behavioral interventions, relative to those receiving standard of care were 3 times more likely to be successful in arranging for their partner's treatment. Thus, partner interventions may hold promise for harnessing the power of relationship dynamics to enhance sexual decision-making, communication, and subsequent health behaviors. The investigators propose to pilot test an intervention designed to change sexual health outcomes by understanding partners and the learning environment related to sex [COUPLES] by simultaneously delivering two evidence-based STI/HIV prevention interventions Sister-to-Sister Teen and Focus on the Future. The simultaneous delivery of effective interventions will be augmented with a joint partner health education counseling session focused on enhancing communication and negotiation of safe sexual practices within the relationship. If successful, this pilot will support the development of a larger trial designed to evaluate the effectiveness of this approach in the busy primary care setting by providing evidence that AYA can and will safely engage their partners in a supportive primary care setting that integrates high quality treatment with evidence-based STI/HIV prevention interventions delivered by health educator teams.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Investigator, Outcomes Assessor)
Masking Description: Single blind
Primary Purpose: Prevention
Official Title: Developing a Dyadic Intervention for STI/HIV Prevention in Youth
Actual Study Start Date : January 15, 2018
Estimated Primary Completion Date : November 1, 2019
Estimated Study Completion Date : November 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS

Arm Intervention/treatment
Active Comparator: Control
Participants will receive individual evidence-based STI/HIV prevention intervention (Sister to Sister Teen for female participants and Focus on the Future for male participants) for STI prevention
Behavioral: Individual evidence-based STI/HIV prevention intervention
Sexual partners will receive individual evidence-based HIV/STI prevention counseling without partner debrief and/or practice negotiating condom use.
Other Name: Sister to Sister / Focus on the Future

Experimental: Intervention
Participants will receive individual evidence-based STI/HIV prevention intervention (Sister to Sister Teen for female participants and Focus on the Future for male participants) for STI prevention plus dyadic counseling and negotiation practice with partner
Behavioral: Intervention
Sexual partners will receive dyadic counseling and support for condom negotiation after receipt of individual evidence based HIV/STI prevention intervention (Sister-to-Sister (female) and Focus on the Future (male).




Primary Outcome Measures :
  1. Feasibility [ Time Frame: 24 months ]
    Recruitment (as a measure of feasibility) will be assessed by calculating the proportion of eligible patients who return with a partner to the study appointment and proportion of dyads who consent to participate in the study.


Secondary Outcome Measures :
  1. Acceptability [ Time Frame: 24 months ]
    Recruitment (as a measure of feasibility) will be assessed by calculating the proportion of eligible patients who return with a partner to the study appointment and proportion of dyads who consent to participate in the study. Retention for the 6-8 week interview will also be calculated as a measure of acceptability.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   16 Years to 30 Years   (Child, Adult)
Sexes Eligible for Study:   All
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Heterosexual dyads based on female and male biology recruited for study.
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

The index patient must be

  • 16-25 years
  • Engage in male-female [heterosexual] intercourse
  • Have ever had a positive STI diagnosis or have received presumptive treatment for an STI
  • Permanently reside in the Greater Baltimore Metropolitan Area (GBMA)
  • Willing to recruit their main sexual partner for the study
  • Willing to participate in a single individual session with a health educator followed by a joint debriefing session together
  • Willing to be contacted in 6 weeks for a telephone interview.
  • The partner must be 16-30 years
  • Engage in male-female [heterosexual] intercourse with the index patient
  • Have a partner with a positive STI diagnosis or received presumptive treatment for an STI ever
  • Permanently reside in the greater Baltimore Metropolitan Area
  • Willing to participate in a single individual session with a health educator followed by a joint debriefing session and to be contacted in 6-8 weeks for a telephone interview.

Exclusion Criteria:

  • Index participants and partners who are unable to communicate with staff or participate in study procedures due to cognitive, mental, or language difficulties will not be eligible for recruitment into the study.
  • Dyads will also be excluded if in same-sex main partnership or a member of the couple is currently enrolled in another sexual behavior study, one or both partners has a known concurrent HIV infection, one or more partners has a pending incarceration, there is more than five years age difference between the two partners and one partner is <16 years of age, or there is evidence of intimate partner violence (IPV) in the relationship.
  • Individuals who screen positive for IPV will be referred to local resources for assistance.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03275168


Contacts
Layout table for location contacts
Contact: Steven Huettner, BS 4103022103 shuettn1@jhmi.edu

Locations
Layout table for location information
United States, Maryland
Johns Hopkins Medicine Recruiting
Baltimore, Maryland, United States, 21287
Contact: Julia Rowell, BA    443-287-1140    jrowel10@jhmi.edu   
Contact: Steven Huettner, BA    4103022103    shuettn1@jhmi.edu   
Sponsors and Collaborators
Johns Hopkins University
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Investigators
Layout table for investigator information
Principal Investigator: Maria E Trent, MD, MPH Johns Hopkins University

Layout table for additonal information
Responsible Party: Johns Hopkins University
ClinicalTrials.gov Identifier: NCT03275168     History of Changes
Other Study ID Numbers: IRB00148707
1R21HD090498-01A1 ( U.S. NIH Grant/Contract )
First Posted: September 7, 2017    Key Record Dates
Last Update Posted: February 5, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: This is a small pilot trial. De-identified data will be presented in aggregate in professional presentations and publications.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Sexually Transmitted Diseases
Infection
Virus Diseases
Genital Diseases, Male
Genital Diseases, Female